Biologics Contract Manufacturing Market Overview
The global biologics contract manufacturing market is estimated to reach over $19 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of ~9% during the forecast period.
Read More: https://www.rootsanalysis....
The biologics contract manufacturing market, also known as the biopharmaceutical CMO market, is a dynamic and rapidly growing sector with a large number of players investing in research and development activities for developing new modalities, such as antibody drug conjugates, biosimilars, and cell and gene therapies.
The global biologics contract manufacturing market is estimated to reach over $19 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of ~9% during the forecast period.
Read More: https://www.rootsanalysis....
The biologics contract manufacturing market, also known as the biopharmaceutical CMO market, is a dynamic and rapidly growing sector with a large number of players investing in research and development activities for developing new modalities, such as antibody drug conjugates, biosimilars, and cell and gene therapies.
Biologics Contract Manufacturing Market Size, Share, Trends, Forecast (2035)
The biologics contract manufacturing market is estimated to be worth $19 billion in 2023 and is expected to grow at a CAGR of 9% during the forecast period.
https://www.rootsanalysis.com/reports/biopharmaceutical-contract-manufacturing-market/250.html
12 months ago
